Ion Exchange margins slip 29% as Roha plant costs bite
Revenue grew 7% to ₹29,148 million, but EBITDA fell to ₹2,102 million. Management targets breakeven for the consumer division in FY2027.
— 1 earlier story on Ion Exchange (India) Ltd. →What's new
- FY2026 EBITDA dropped 29% to ₹2,102 million on Roha plant costs and West Asia instability.
- Engineering order book stands at ₹26,433 million, covering three quarters of work.
- Mann+Hummel partnership signed for ultrafiltration membrane production.
Why this matters
The margin compression shows the friction of scaling new manufacturing capacity during geopolitical volatility. The company's ability to hit its FY2027 consumer-division breakeven target is the primary test of its current strategy.
What we're watching
- Progress on narrowing losses in the consumer products division.
- Execution speed on the new Oman and Malawi international projects.
- Stabilization of input costs affecting legacy project margins.
The full read
Ion Exchange (India) faced a difficult year for profitability. EBITDA fell 29% to ₹2,102 million despite a 7% rise in annual revenue to ₹29,148 million.
The margin squeeze is tied to the costs of ramping up the Roha plant and the impact of the West Asia crisis on operations. The company is tapping into technology and international growth to offset these pressures, securing a partnership with Mann+Hummel for ultrafiltration membranes and adding projects in Oman and Malawi. Its engineering order book of ₹26,433 million offers three quarters of visibility, providing a buffer as it manages legacy project delays. The consumer products division, which grew 34% to ₹1,047 million, remains a focus area with a target to reach breakeven by FY2027.
Input costs remain volatile. The open question is whether the company can contain these expenses while scaling its new manufacturing footprint.
Questions answered
- What caused the 29% drop in EBITDA?
- The decline stems from ramp-up costs at the new Roha plant and operational headwinds caused by the ongoing crisis in West Asia.
- How much revenue did the company generate in FY2026?
- Ion Exchange reported annual revenue of ₹29,148 million, a 7% increase over the prior year.
- What is the status of the consumer products division?
- The division grew 34% to ₹1,047 million and narrowed its losses. Management expects the unit to reach breakeven in FY2027.
- What does the current order book look like?
- The engineering order book is valued at ₹26,433 million, which management expects will provide three quarters of revenue visibility.
Story so far
All notes on IONEXCHANG →- 29 May 2026 · 4:21 PM IST Ion Exchange margins slip 29% as Roha plant costs bite
- 4d ago Ion Exchange profit drops 35% as margins buckle under costs